Melvin LK CHUA | FRCR, PhD, FASCO (@DrMLChua)

Pinned

M

Melvin LK CHUA | FRCR, PhD, FASCO@DrMLChua · Mar 2, 2023

Finally came in the post! The go-to “Devita” txtbk everyone uses for their Boards & residencies for ready info updated & reformatted to suit the rapidly changing field of Oncology. Glad to have contributed to the #Nasopharynxcancer chapter & see familiar names @DrSpratticus

DrMLChua's tweet image. Finally came in the post!

The go-to “Devita” txtbk everyone uses for their Boards &amp; residencies for ready info updated &amp; reformatted to suit the rapidly changing field of Oncology.

Glad to have contributed to the #Nasopharynxcancer chapter &amp; see familiar names @DrSpratticus

4

10

80

1

15.0K

M

Melvin LK CHUA | FRCR, PhD, FASCO@DrMLChua · Jul 26

What a fruitful way to spend a Sat AM with #HeadNeckCancer experts discussing about #OralCavity cancers Thanks to @DrGopalIyer Prof Sarbani from @TataMemorial for the lectures! And @ASCO for the support of the #MultidisciplinaryCancer #MCMC course for Sarawak General Hospital!

DrMLChua's tweet image. What a fruitful way to spend a Sat AM with #HeadNeckCancer experts discussing about #OralCavity cancers

Thanks to @DrGopalIyer Prof Sarbani from @TataMemorial for the lectures! And @ASCO for the support of the #MultidisciplinaryCancer #MCMC course for Sarawak General Hospital!

2

3

19

0

613

M

Melvin LK CHUA | FRCR, PhD, FASCO@DrMLChua · Jul 12

Always fun to spend a productive morning sharing on #ProtonBeam in cancers particularly #HeadNeckCancer with the Singapore Cancer Society community of #patients and #survivors Equally impactful as giving academic talks! It is humbling to have patient sharing their experiences!

DrMLChua's tweet image. Always fun to spend a productive morning sharing on #ProtonBeam in cancers particularly #HeadNeckCancer with the Singapore Cancer Society community of #patients and #survivors
Equally impactful as giving academic talks!
It is humbling to have patient sharing their experiences!

1

0

13

0

477

Melvin LK CHUA | FRCR, PhD, FASCO Retweeted

A

AACR President Lillian L. Siu@AACRPres · Jul 4

It was my pleasure to help open the 5th International Congress of the Asian Oncology Society and 51st Annual Meeting of the Korean Cancer Association here in Seoul. @AACR is proud to work with our colleagues in Korea and all 15 AOS member countries to advance our shared mission.

0

4

37

1

3.0K

M

Melvin LK CHUA | FRCR, PhD, FASCO@DrMLChua · Jul 3

We know that TILs are abundant in #NasopharyngealCarcinoma While it is certainly more complex than quantity, previous work indicated that %TILs may be prognostic in NPC We took the FIRST step using #DeepLearning to read H+E slides. More to come! sciencedirect.com/science/articl…

3

5

18

0

1.0K

Melvin LK CHUA | FRCR, PhD, FASCO Retweeted

S

Shankar Siva@_ShankarSiva · Jun 25

🥳 Today, we randomised the final patient on @TROGfightcancer 19.06 DECREASE trial! This trial randomised patients with prostate cancer who were becoming resistant to hormone therapy, without evidence of metastases on bone or CT scan, to Darolutamide +/- Stereotactic…

9

34

128

11

8.0K

M

Melvin LK CHUA | FRCR, PhD, FASCO@DrMLChua · Jun 24

Join us at #ASTRO25 !@CJTsaiMDPhD @jdschoenfeld1 @_ShankarSiva

SSameer Keole@SameerKeoleMD · Jun 23

I hope to see you at the @ASTRO_org 2025 Annual Meeting Sep 27 to Oct 1. You will not want to miss this novel educational session led by @drdavidpalma on emerging indications for RT in polymetastatic cancers. It is timely and on point for the AM theme amportal.astro.org/sessions/edu-0…

1

0

6

0

435

Melvin LK CHUA | FRCR, PhD, FASCO Retweeted

S

Sameer Keole@SameerKeoleMD · Jun 23

I hope to see you at the @ASTRO_org 2025 Annual Meeting Sep 27 to Oct 1. You will not want to miss this novel educational session led by @drdavidpalma on emerging indications for RT in polymetastatic cancers. It is timely and on point for the AM theme amportal.astro.org/sessions/edu-0…

0

8

29

1

3.0K

M

Melvin LK CHUA | FRCR, PhD, FASCO@DrMLChua · Jun 24

Welcome back @drdavidpalma !

DDavid Palma, MD, PhD@drdavidpalma · Jun 23

I decided to rejoin X because there just isn't the same #radonc community on the other platforms. Over the next couple of days, I'll post some updates on some research and the ARC Bootcamp. Thanks @_ShankarSiva for the nudge to come back!

0

2

0

338

Melvin LK CHUA | FRCR, PhD, FASCO Retweeted

D

David Palma, MD, PhD@drdavidpalma · Jun 23

I decided to rejoin X because there just isn't the same #radonc community on the other platforms. Over the next couple of days, I'll post some updates on some research and the ARC Bootcamp. Thanks @_ShankarSiva for the nudge to come back!

10

9

108

2

7.0K

M

Melvin LK CHUA | FRCR, PhD, FASCO@DrMLChua · Jun 18

What a #Legend He was one of the few who always kept it FUN and REAL and left a lasting impression when I first heard him speak at @ASTRO_org Annual Meeting @a_dalpra @aleberlin2 @DrSpratticus @VedangMurthy @seanmmcbride @drkevin_chua_lm @mikemejiamd @_ShankarSiva

HHenning Willers, MD, FASTRO@HenningWillers · Jun 17

📢Special day: Literally Dr. Anthony Zietman's Last Day in #radonc clinic😳🥳😔 After 3️⃣9️⃣ years of service🙏🙏🙏 Handing the torch 🔥(for the clinic space that is😉) to @sophia_kamran 😅 A loss for our field, but he is going out on top‼️⛰️ @sueyom

3

4

25

1

2.0K

M

Melvin LK CHUA | FRCR, PhD, FASCO@DrMLChua · Jun 17

What a great summary on treatment of #Oligometastatic #ProstateCancer ! Congrats @VedangMurthy @drmaneesh_singh @piet_ost Good learning for every Resident and Senior Faculty! 💪🏻💪🏻

MManeesh Singh@drmaneesh_singh · Jun 15

Thrilled and Grateful. Our review on metastasis-directed therapy in oligometastatic prostate cancer is now out in Seminars in Radiation Oncology. Thank you so much @VedangMurthy @piet_ost for your guidance and belief! Full text authors.elsevier.com/c/1lFrI3lXQoc1…

1

13

36

12

3.0K

M

Melvin LK CHUA | FRCR, PhD, FASCO@DrMLChua · Jun 15

Thrilled and Grateful. Our review on metastasis-directed therapy in oligometastatic prostate cancer is now out in Seminars in Radiation Oncology. Thank you so much @VedangMurthy @piet_ost for your guidance and belief! Full text authors.elsevier.com/c/1lFrI3lXQoc1…

VVedang Murthy@VedangMurthy · Jun 15

2️⃣ Metastasis Directed Therapy in Oligometastatic Prostate Cancer 👥 With @drmaneesh_singh & @piet_ost 🧠 A deep dive into MDT’s role: trial data, timing, integration with systemic Rx. 🚀 Covering both HSPC and CRPC. Read 📖 doi.org/10.1016/j.semr… With an image for the ages!

5

22

54

17

7.0K

M

Melvin LK CHUA | FRCR, PhD, FASCO@DrMLChua · Jun 14

Interesting poll from #NasopharyngealCarcinoma Meeting in Guangzhou among Chinese Experte What should be the SOC for high-risk NPC trial? @imrtlee @Qle_stanford @sueyom @mikemejiamd @lachiemcd @Larvol @oncodaily In case translation is needed, option 1 is IC+CRT and option 2…

DrMLChua's tweet image. Interesting poll from #NasopharyngealCarcinoma
Meeting in Guangzhou among Chinese Experte

What should be the SOC for high-risk NPC trial? @imrtlee @Qle_stanford @sueyom @mikemejiamd @lachiemcd @Larvol @oncodaily

In case translation is needed, option 1 is IC+CRT and option 2…

2

13

0

824

M

Melvin LK CHUA | FRCR, PhD, FASCO@DrMLChua · Jun 14

Always nice to visit Guangzhou for another #NasopharyngealCarcinoma #ProtonTherapy meeting to discuss practice in the real world. OS rates may be improving >70%, BUT still lots of patients with bad disease and early relapse so lots more to do! Thanks to Prof Mai for the…

DrMLChua's tweet image. Always nice to visit Guangzhou for another #NasopharyngealCarcinoma
#ProtonTherapy meeting to discuss practice in the real world.

OS rates may be improving &gt;70%, BUT still lots of patients with bad disease and early relapse so lots more to do!

Thanks to Prof Mai for the…

0

3

20

1

886

Melvin LK CHUA | FRCR, PhD, FASCO Retweeted

J

Julie Gralow@jrgralow · Jun 2

It’s official! Dr. Eric Small assumes his role as @asco 2025-26 president and introduces his theme. #asco25 @ASCOPres

0

24

117

0

7.0K

Melvin LK CHUA | FRCR, PhD, FASCO Retweeted

L

LARVOL@Larvol · Jun 2

1

12

32

4

3.0K

M

Melvin LK CHUA | FRCR, PhD, FASCO@DrMLChua · Jun 2

#ASCO2025 #PresidentReception Learning something from the 🤴 of #selfies @PGrivasMDPhD @drkevin_chua_lm Such a great gathering of people and I can’t help but promote #ASCOBT2026 #ASCOBreakthrough when you have Singapore sling as a cocktail drink!

DrMLChua's tweet image. #ASCO2025
#PresidentReception

Learning something from the 🤴 of #selfies @PGrivasMDPhD @drkevin_chua_lm

Such a great gathering of people and I can’t help but promote #ASCOBT2026 #ASCOBreakthrough when you have Singapore sling as a cocktail drink!

0

1

18

0

461

M

Melvin LK CHUA | FRCR, PhD, FASCO@DrMLChua · Jun 1

The field of #HeadNeckCancer just got more interesting! #ASCO2025 #Plenary NIVO-POSTOP study was an important IIS for high risk HNSCC Positive DFS @ 3y But signal is primarily locoregional control! Stark contrast to KN689 Kudos to GORTEC @PBlanchardMD Thoughts??

DrMLChua's tweet image. The field of #HeadNeckCancer just got more interesting!

#ASCO2025
#Plenary

NIVO-POSTOP study was an important IIS for high risk HNSCC
Positive DFS @ 3y
But signal is primarily locoregional control!
Stark contrast to KN689

Kudos to GORTEC @PBlanchardMD
Thoughts??

4

22

55

14

5.0K